Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peyronie's disease

J Chesney

    British Journal of Urology
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Peyronie's disease treatment with procarbazine (Natulan) shows effectiveness in selected patients. Careful application of this therapy is recommended for optimal outcomes in managing this condition.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Long-term outcomes among patients who respond within the first year to nivolumab plus ipilimumab or nivolumab monotherapy: A pooled analysis in 935 patients.

    European journal of cancer (Oxford, England : 1990)·2024
    Same author

    Clinical development of cancer therapeutics that target metabolism.

    QJM : monthly journal of the Association of Physicians·2015
    Same author

    6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.

    Cell death & disease·2014
    Same author

    Regulation of glycolytic and mitochondrial metabolism by ras.

    Current pharmaceutical biotechnology·2011
    Same author

    A novel small molecule antagonist of choline kinase-α that simultaneously suppresses MAPK and PI3K/AKT signaling.

    Oncogene·2011
    Same author

    The Use of Stilboestrol in the Treatment of Carcinoma of the Prostate.

    Postgraduate medical journal·2011
    Same journal

    Removal of ureteric calculus by the ureteric corkscrew in a case of calculous anuria.

    British journal of urology·2010
    Same journal

    Obstructive anuria, probably due to calculus.

    British journal of urology·2010
    Same journal

    The incidence of signs of renal injury following prolonged burial under debris in an unselected series of 764 airraid casualties admitted to hospital.

    British journal of urology·2010
    Same journal

    Contribution to the etiology of acquired fibrosis of the bladder neck.

    British journal of urology·2010
    Same journal

    True infective abacterial pyuria.

    British journal of urology·2010
    Same journal

    A malignant right kidney removed at operation, together with a short length of the vena cava.

    British journal of urology·2010
    See all related articles

    Area of Science:

    • Urology
    • Andrology
    • Pharmacology

    Background:

    • Peyronie's disease is a condition characterized by fibrous scar tissue development.
    • This condition can lead to penile curvature and erectile dysfunction.

    Purpose of the Study:

    • To review the history and clinical features of Peyronie's disease.
    • To present the results of procarbazine treatment for Peyronie's disease.

    Main Methods:

    • Literature review on Peyronie's disease history and clinical presentation.
    • Analysis of treatment outcomes using procarbazine (Natulan).

    Main Results:

    • Procarbazine (Natulan) demonstrated effectiveness in treating Peyronie's disease.
    • Treatment success was observed in a specific patient cohort.

    Conclusions:

    • Procarbazine (Natulan) is an effective treatment option for selected patients with Peyronie's disease.
    • Appropriate precautions are essential for safe and effective procarbazine therapy.